Erratum: Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase i trials (Invest New Drugs DOI: 10.1007/s10637-011-9671-z)

Antonin Levy; Laurence Albiges-Sauvin; Christophe Massard; Hassan Izzedine; Stéphane Ederhy; Ratio Bahleda; Carlos Gomez-Roca; Cyrus Chargari; Isabelle Brocheriou-Spelle; Jean Charles Soria

doi:10.1007/s10637-011-9783-5

Erratum: Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase i trials (Invest New Drugs DOI: 10.1007/s10637-011-9671-z)

Antonin Levy, Laurence Albiges-Sauvin, Christophe Massard, Hassan Izzedine, Stéphane Ederhy, Ratio Bahleda, Carlos Gomez-Roca, Cyrus Chargari, Isabelle Brocheriou-Spelle, Jean Charles Soria

Résultats de recherche: Contribution à un journal › !!Comment/debate

langue originale	Anglais
Pages (de - à)	1276
Nombre de pages	1
journal	Investigational New Drugs
Volume	30
Numéro de publication	3
Les DOIs	https://doi.org/10.1007/s10637-011-9783-5
état	Publié - 1 juin 2012
Modification externe	Oui

Accès au document

10.1007/s10637-011-9783-5

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Levy, A., Albiges-Sauvin, L., Massard, C., Izzedine, H., Ederhy, S., Bahleda, R., Gomez-Roca, C., Chargari, C., Brocheriou-Spelle, I., & Soria, J. C. (2012). Erratum: Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase i trials (Invest New Drugs DOI: 10.1007/s10637-011-9671-z). Investigational New Drugs, 30(3), 1276. https://doi.org/10.1007/s10637-011-9783-5

@article{af79aa4fc1f042f781cb483b0b8d541a,

title = "Erratum: Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase i trials (Invest New Drugs DOI: 10.1007/s10637-011-9671-z)",

author = "Antonin Levy and Laurence Albiges-Sauvin and Christophe Massard and Hassan Izzedine and St{\'e}phane Ederhy and Ratio Bahleda and Carlos Gomez-Roca and Cyrus Chargari and Isabelle Brocheriou-Spelle and Soria, {Jean Charles}",

year = "2012",

month = jun,

day = "1",

doi = "10.1007/s10637-011-9783-5",

language = "English",

volume = "30",

pages = "1276",

journal = "Investigational New Drugs",

issn = "0167-6997",

number = "3",

}

Levy, A, Albiges-Sauvin, L, Massard, C, Izzedine, H, Ederhy, S, Bahleda, R, Gomez-Roca, C, Chargari, C, Brocheriou-Spelle, I & Soria, JC 2012, 'Erratum: Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase i trials (Invest New Drugs DOI: 10.1007/s10637-011-9671-z)', Investigational New Drugs, VOL. 30, Numéro 3, p. 1276. https://doi.org/10.1007/s10637-011-9783-5

Erratum: Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase i trials (Invest New Drugs DOI: 10.1007/s10637-011-9671-z). / Levy, Antonin; Albiges-Sauvin, Laurence; Massard, Christophe et al.
Dans: Investigational New Drugs, Vol 30, Numéro 3, 01.06.2012, p. 1276.

Résultats de recherche: Contribution à un journal › !!Comment/debate

TY - JOUR

T1 - Erratum

T2 - Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase i trials (Invest New Drugs DOI: 10.1007/s10637-011-9671-z)

AU - Levy, Antonin

AU - Albiges-Sauvin, Laurence

AU - Massard, Christophe

AU - Izzedine, Hassan

AU - Ederhy, Stéphane

AU - Bahleda, Ratio

AU - Gomez-Roca, Carlos

AU - Chargari, Cyrus

AU - Brocheriou-Spelle, Isabelle

AU - Soria, Jean Charles

PY - 2012/6/1

Y1 - 2012/6/1

UR - http://www.scopus.com/inward/record.url?scp=84864344812&partnerID=8YFLogxK

U2 - 10.1007/s10637-011-9783-5

DO - 10.1007/s10637-011-9783-5

M3 - Comment/debate

AN - SCOPUS:84864344812

SN - 0167-6997

VL - 30

SP - 1276

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 3

ER -